Hypersensitization of the Orexin 1 Receptor by the CB1 ReceptorSandrine Hilairet, Pierre Casellas|Journal of Biological Chemistry|2003Cited by 185
CEP-7055: a novel, orally active pan inhibitor of vascular endothelial growth factor receptor tyrosine kinases with potent antiangiogenic activity and antitumor efficacy in preclinical models.Bruce Ruggeri, Craig A. Dionne, Thelma S. Angeles et al.|PubMed|2003Cited by 124